14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $35.67 $42.91 Friday, 3rd May 2024 CLDX stock ended at $42.56. This is 4.16% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.80% from a day low at $41.34 to a day high of $42.91.
90 days $35.03 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
May 05, 2023 $31.52 $33.91 $31.52 $33.28 660 566
May 04, 2023 $30.90 $31.92 $30.49 $31.49 514 285
May 03, 2023 $31.06 $32.64 $31.06 $31.46 566 530
May 02, 2023 $31.19 $31.67 $30.44 $30.85 697 837
May 01, 2023 $31.51 $32.31 $31.28 $31.35 502 423
Apr 28, 2023 $31.41 $31.50 $30.60 $31.44 509 590
Apr 27, 2023 $32.29 $33.18 $31.58 $31.73 525 378
Apr 26, 2023 $33.89 $34.06 $32.05 $32.33 434 420
Apr 25, 2023 $34.66 $35.47 $33.78 $33.98 412 270
Apr 24, 2023 $36.51 $36.76 $34.68 $34.73 398 648
Apr 21, 2023 $35.88 $36.98 $35.58 $36.62 568 677
Apr 20, 2023 $36.37 $36.50 $35.24 $35.89 600 456
Apr 19, 2023 $34.16 $36.88 $33.58 $36.45 794 043
Apr 18, 2023 $32.55 $34.55 $32.08 $34.37 838 139
Apr 17, 2023 $30.35 $33.19 $30.35 $32.45 1 791 613
Apr 14, 2023 $31.31 $31.59 $29.68 $30.29 1 144 739
Apr 13, 2023 $31.08 $31.91 $31.08 $31.55 1 960 602
Apr 12, 2023 $31.68 $31.73 $30.79 $30.96 846 654
Apr 11, 2023 $31.69 $32.20 $31.27 $31.41 435 814
Apr 10, 2023 $32.18 $32.32 $30.74 $31.50 1 006 960
Apr 06, 2023 $33.18 $33.61 $32.06 $32.40 893 612
Apr 05, 2023 $35.12 $35.36 $33.17 $33.18 979 203
Apr 04, 2023 $35.74 $36.09 $34.73 $35.30 722 143
Apr 03, 2023 $35.54 $37.30 $35.51 $35.81 614 495
Mar 31, 2023 $35.91 $36.15 $35.19 $35.98 572 785
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT